MedCity News

SEPTEMBER 9, 2024

The weight loss results for the Terns Pharmaceuticals drug TERN-601 come from a four-week Phase 1 clinical trial. The post Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study appeared first on MedCity News.

Leads 121

Leads Pharma Pharmaceutical Medical 121

Pharmaceutical Technology

SEPTEMBER 23, 2024

Download our free, extensive list of the leading Active Pharmaceutical Ingredients and Intermediates companies and suppliers today.

Pharmaceutical 98

Pharmaceutical Leads 98

MedCity News

NOVEMBER 14, 2023

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”

Leads 115

Leads Pharma Pharmaceutical Patients 115

European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. AI and future perspectives: a glimpse into tomorrow Figure 2: adapted from Saha, G.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

Pharmaceutical Technology

SEPTEMBER 24, 2024

Discover the leading Pharmaceutical Packaging Companies, Suppliers & Solutions. Download the free Buyer's Guide today for full details.

Pharmaceutical 95

Pharmaceutical Manufacturing Leads 95

MedCity News

FEBRUARY 12, 2024

FDA approval of Takeda Pharmaceutical drug Eohilia introduces a new therapeutic option for patients with eosinophilic esophagitis, inflammation of the esophagus that causes swallowing difficulty. It will compete against Dupixent, a Sanofi and Regeneron Pharmaceuticals drug already approved for this disorder.

FDA 119

FDA Leads Pharmaceutical Patients 119

European Pharmaceutical Review

JULY 4, 2024

The post ‘Accidental’ media switch leads to CAR T therapy discovery appeared first on European Pharmaceutical Review.

Media 116

Media Leads Manufacturing Patients 116

European Pharmaceutical Review

APRIL 18, 2024

The post Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment appeared first on European Pharmaceutical Review. Gepotidacin is an investigational bactericidal, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a novel mechanism of action, according to GSK.

Leads 105

Leads Safety Patients Pharmaceutical 105

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. What were the main challenges for pharmaceutical microbiology in 2022?

Pharmaceutical 128

Pharmaceutical Food and Drug Administration Manufacturing Medicine 128

European Pharmaceutical Review

MAY 22, 2024

The post European authorities recognised for leading medicine regulatory oversight appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Leads Food and Drug Administration Safety 93

European Pharmaceutical Review

FEBRUARY 14, 2024

A report by Allied Market Research predicts that the global pharmaceutical suspension market will reach $83.8 The research specified that the parenteral administration sector accounted for more than half of the global pharmaceutical suspension market in 2022. billion by 2032. Having valued $55.5 percent between 2023 and 2032.

Pharmaceutical 95

Pharmaceutical Marketing Medicine Healthcare 95

Pharmaceutical Technology

SEPTEMBER 23, 2024

View the top artificial intelligence (AI) companies in the pharmaceutical industry and download your free guide to AI in pharma here.

Pharma 98

Pharma Leads Pharmaceutical 98

European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). A well-designed wastewater sampling plan will ensure that representative samples are collected.

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

European Pharmaceutical Review

JANUARY 29, 2024

1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way to resolution.

Pharmaceutical 111

Pharmaceutical Food and Drug Administration Medicine FDA 111

MedCity News

SEPTEMBER 20, 2023

In the realm of pharmaceuticals, where innovation can be the difference between life and death, the emergence of generative AI, has been nothing short of transformative. By harnessing the capabilities of AI, the pharmaceutical industry is unlocking novel possibilities that were once deemed unattainable.

Ethics 119

Ethics Medicine Pharmaceutical Pharmaceutical research 119

European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 105

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. appeared first on European Pharmaceutical Review.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Meath opened last month.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

European Pharmaceutical Review

APRIL 19, 2024

The paper reported that benefits of these alternative methodologies include “the ability to respond more quickly to adverse microbiological results, as well as leading to fewer waste products”. The post Microbial burden assessment of solid pharmaceutical products appeared first on European Pharmaceutical Review.

Pharmaceutical products 98

Pharmaceutical products Pharmaceutical Pharmacology Leads 98

European Pharmaceutical Review

DECEMBER 4, 2023

The (bio)pharmaceutical industry is currently facing numerous hurdles in its path to high-efficiency production that are more complex and pressing than ever before. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. Enter the era of benchtop NMR solutions.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

MedCity News

JANUARY 16, 2024

The FDA approved Vertex Pharmaceuticals’ gene therapy Casgevy for treating beta thalassemia, an inherited blood disease that leads to low levels of functioning hemoglobin. Last month, the one-time treatment won its first FDA nod for treating sickle cell disease.

FDA 134

FDA Pharmaceutical Leads Biopharma 134

European Pharmaceutical Review

DECEMBER 20, 2023

In Q1 2023, the European Commission (EC) announced proposed changes to EU pharmaceutical legislation. 1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. This could in turn lead to loss of benefits associated with orphan designation status (e.g.,

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

Fierce Pharma

JULY 10, 2024

Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. | In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma's 10 highest-paid CEOs.”

Specialization 147

Specialization Pharma Leads Pharmaceutical 147

MedCity News

MARCH 19, 2024

AstraZeneca’s Fusion Pharmaceuticals acquisition is the latest in a wave of M&A activity that includes recent deals by Eli Lilly and Bristol Myers Squibb. The lead Fusion program is in mid-stage clinical development for treating advanced prostate cancer.

Pharmaceutical 126

Pharmaceutical Leads Biopharma Pharma 126

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. Can small biotech companies survive? Bernie Sanders, I-Vt.,

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

Pharmaceutical Technology

JANUARY 29, 2024

The rapid sequencing of the SARS-CoV-2 and the subsequent development of mRNA vaccines led to the authorisation of the first of these vaccines in late 2020.

Leads 111

Leads 111

MedCity News

APRIL 10, 2024

Vertex Pharmaceuticals gains a Phase 3-ready Alpine Immune Sciences drug with potential applications in a wide range of immunological disorders. The lead indication for the Alpine drug, povetacicept, is the chronic kidney disease IgA nephropathy. The post Vertex Pharma Bolsters Immunology Profile With $4.9B

Pharma 120

Pharma Pharmaceutical Leads Biopharma 120

World of DTC Marketing

MAY 7, 2021

The Washington Post reported last year that health and pharmaceutical companies spent almost $1 billion on just Facebook mobile ads in 2019. A complete waste of money, time and effort.

Media 283

Media Prescription Marketing Pharma 283

MedCity News

OCTOBER 20, 2024

Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, a panel discussed these applications and more.

Pharma 132

Pharma Leads Pharmaceutical Biopharma 132

Pharma Marketing Network

DECEMBER 19, 2024

For marketing executives, understanding the significance of leading pharma brands is essential. Top Pharma Brands and Their Strategies The pharmaceutical industry is home to some of the most recognizable brands worldwide. As the industry evolves, staying proactive will be key to thriving in the ever-changing pharmaceutical landscape.

Leads 52

Leads Pharma Education Marketing 52

World of DTC Marketing

NOVEMBER 1, 2020

Fauci, the country’s leading infectious-disease expert, said in a wide-ranging interview late Friday. Fauci, a leading member of the government’s coronavirus response, said the United States needed to make an “abrupt change” in public health practices and behaviors. We’re in for a whole lot of hurt. In one recent example, Pfizer?

Healthcare 188

Healthcare Healthcare Food and Drug Administration Distribution 188

MedCity News

AUGUST 1, 2024

Otsuka Pharmaceutical is acquiring Jnana Therapeutics, whose lead drug is a potential treatment for the rare metabolic disorder phenylketonuria (PKU). Jnana’s drug could provide an alternative to two FDA-approved PKU medicines from BioMarin Pharmaceutical.

Pharmaceutical 105

Pharmaceutical Medicine FDA Leads 105

European Pharmaceutical Review

JUNE 4, 2024

Based on electromagnetic levitation, TILE-X is a compact, Grade A, gloveless modular processing unit for high-value pharmaceuticals such as ATMPs. The post The IMA Group at ACHEMA 2024 : All-In-One solutions for the pharmaceutical sector appeared first on European Pharmaceutical Review. We look forward to seeing you at Hall 3.0,

Pharmaceutical 95

Pharmaceutical Pharma Manufacturing Training 95

MedCity News

MAY 22, 2023

Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.

Pharmaceutical 118

Pharmaceutical Leads Biopharma Pharma 118

MedCity News

MAY 18, 2023

rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline. The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy. By selling U.S.

Pharma 119

Pharma Pharmaceutical Leads Biopharma 119

eMediWrite

NOVEMBER 22, 2024

Becoming an outstanding product manager in the pharmaceutical industry and creating a top-tier brand demands a blend of strategic insight, industry expertise, and flawless execution. Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly.

Leads 52

Leads Pharma Marketing Healthcare Provider 52

World of DTC Marketing

DECEMBER 29, 2020

A key consideration is funding – public and private cash has been poured into the race for a Covid vaccine, pushing aside the usual financial concerns facing pharmaceutical companies. Then there are the finances. All vaccines go through clinical trials to test safety and effectiveness. The post How did pharma develop a vaccine so quickly?

Pharma 307

Pharma Food and Drug Administration Media Food 307